You are here

News

Coverage of the latest news and updates from the field of stem cells and regenerative medicine.

May 14, 2020

SAN DIEGO, CA (US), May 2020 — Global Institute of Stem Cell Therapy and Research (GIOSTAR) has received approval for a COVID-19 clinical trial, led by medical director Prabhat Soni, M.D.

May 11, 2020

ABU DHABI (AE), May 2020 — A patent has been granted by the United Arab Emirates Ministry of Economy for the development of a promising treatment for COVID-19 infections using stem cells.

May 11, 2020

HELSINKI (FI), May 2020 — Graft-versus-host disease (GvHD) is a potentially life-threatening medical condition that is common after allogeneic hematopoietic stem cell transplantation, the only curative treatment for various types of leukemias.

May 11, 2020

ZURICH (CH), May 2020 — Acute myeloid leukemia (AML) is an aggressive cancer of the blood-forming system. It affects the hematopoietic stem cells, or blood stem cells, of various white blood cells and of the red blood cells and platelets.

May 7, 2020

CORONA, CA, and MIAMI, FL, (US), April 2020 — RESTEM, a biotechnology company, and Baptist Health South Florida, announced that three COVID-19 patients with acute respiratory distress syndrome (ARDS) are the first to successfully be treated

May 7, 2020

PHILADELPHIA, PA (US), May 2020 — Like power lines in an electrical grid, long wiry projections that grow outward from neurons — structures known as axons — form interconnected communication networks that run from the brain to all parts of the b

May 4, 2020

TORONTO (CA), May 2020 — A group of researchers from University of Toronto Engineering and SickKids Hospital have developed a new way to deliver molecules that target specific genes within cells.

May 4, 2020

NEUHERBERG (DE), May 2020 — The loss of insulin-secreting beta cells by autoimmune destruction leads to type 1 diabetes. Clinical islet cell transplantation has the potential to cure diabetes, but donor pancreases are rare.

May 4, 2020

CHAMPAIGN, IL (US), May 2020 — In regenerative medicine, an ideal treatment for patients whose muscles are damaged from lack of oxygen would be to invigorate them with an injection of their own stem cells.

May 1, 2020

OSAKA (JP), April 2020 — Corneal diseases often require a transplant using corneal tissue from a donor. Now, researchers from Osaka University developed a novel method that could be used to generate corneal tissue in a lab more easily.

Pages